Maria Horga
Chief Tech/Sci/R&D Officer chez ATEA PHARMACEUTICALS, INC.
Fortune : 103 683 $ au 31/03/2024
Profil
Maria Arantxa Horga is currently the Chief Medical Officer at Atea Pharmaceuticals, Inc. She previously worked as the Group Director-Global Clinical Research at Bristol Myers Squibb Co. and as the Head-Translational Medicine at F.
Hoffmann-La Roche Ltd.
from 2012 to 2016.
She also served as the Vice President-Pharmacovigilance & Medical Affairs at Biohaven Pharmaceuticals, Inc. from 2019 to 2020, and as the Vice President & Global Head-Clinical Program at Roche Innovation Center from 2017 to 2019.
Dr. Horga obtained her doctorate degree from the University of Santander.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/02/2024 | 25 664 ( 0,03% ) | 103 683 $ | 31/03/2024 |
Postes actifs de Maria Horga
| Sociétés | Poste | Début |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2020 |
Anciens postes connus de Maria Horga
| Sociétés | Poste | Fin |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01/08/2020 |
| Roche Innovation Center | Corporate Officer/Principal | 01/08/2019 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Formation de Maria Horga
| University of Santander | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
| Roche Innovation Center |
